Provectus Biopharmaceuticals Inc (PVCT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH82168D
- Pages: 31
- October 2018
- Region : North America
- GlobalData
- Equity Research Report
- Details
- Table Of Content
- Licence Rights
- Section Purchase
- Products and Companies
Details
Summary
Provectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], pediatric solid tumors and other tumors. It is developing a new class of drugs based on halogenated xanthenes such as Rose Bengal. Provectus offers PH-10 for psoriasis and atopic dermatitis. The company conducts research on ongoing clinical trials for indications including breast cancers, melanoma, head and neck cancers, basal cell carcinoma and squamous cell carcinoma. It operates through its offices in Tennessee and New York, the US. Provectus is headquartered in Knoxville, Tennessee, the US.
Provectus Biopharmaceuticals Inc (PVCT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Provectus Biopharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Provectus Biopharma Enters into Research Agreement with POETIC 11
Licensing Agreements 12
Provectus to Enter into Licensing Agreement with Sinopharm-CSIPI and Sinopharm A-THINK for PV-10 12
Equity Offering 14
Provectus Biopharma Raises USD6 Million in Public Offering of Series B Preferred Stock and Warrants 14
Provectus Biopharma Raises USD0.8 Million in Private Placement of Shares 16
Provectus Biopharma Raises USD1 Million in Private Placement of Shares 17
Provectus Biopharma Raises USD13.1 Million in Public Offering of Shares and Warrants 18
Provectus Biopharma Raises USD5 Million in Private Placement of Shares 20
Provectus Biopharma Raises USD3.6 Million in Private Placement of Shares 21
Provectus Biopharma Raises USD4.2 Million in Private Placement of Shares 22
Provectus Pharma Announces Private Placement Of Shares For Up To USD 30 Million 23
Provectus Pharma Completes Private Placement Of Units For USD 2 Million 24
Provectus Pharma Completes Private Placement Of Units For USD 2.1 Million 25
Provectus Biopharmaceuticals Inc-Key Competitors 26
Provectus Biopharmaceuticals Inc-Key Employees 27
Provectus Biopharmaceuticals Inc-Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Corporate Communications 29
Apr 20, 2017: Provectus Biopharmaceuticals Reestablishes Strategic Advisory Board 29
Feb 23, 2017: Provectus Biopharmaceuticals Appoints Bruce Horowitz And Dominic Rodrigues As Special Advisers To The Board Of Directors 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31
List Of Figure
List of Figures
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Provectus Biopharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
List Of Table
List of Tables
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Provectus Biopharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Provectus Biopharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Provectus Biopharma Enters into Research Agreement with POETIC 11
Provectus to Enter into Licensing Agreement with Sinopharm-CSIPI and Sinopharm A-THINK for PV-10 12
Provectus Biopharma Raises USD6 Million in Public Offering of Series B Preferred Stock and Warrants 14
Provectus Biopharma Raises USD0.8 Million in Private Placement of Shares 16
Provectus Biopharma Raises USD1 Million in Private Placement of Shares 17
Provectus Biopharma Raises USD13.1 Million in Public Offering of Shares and Warrants 18
Provectus Biopharma Raises USD5 Million in Private Placement of Shares 20
Provectus Biopharma Raises USD3.6 Million in Private Placement of Shares 21
Provectus Biopharma Raises USD4.2 Million in Private Placement of Shares 22
Provectus Pharma Announces Private Placement Of Shares For Up To USD 30 Million 23
Provectus Pharma Completes Private Placement Of Units For USD 2 Million 24
Provectus Pharma Completes Private Placement Of Units For USD 2.1 Million 25
Provectus Biopharmaceuticals Inc, Key Competitors 26
Provectus Biopharmaceuticals Inc, Key Employees 27
Provectus Biopharmaceuticals Inc, Subsidiaries 28
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
Products and Companies
Products
Provectus Biopharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Summary
Provectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], pediatric solid tumors and other tumors. It is developing a new class of drugs based on halogenated xanthenes such as Rose Bengal. Provectus offers PH-10 for psoriasis and atopic dermatitis. The company conducts research on ongoing clinical trials for indications including breast cancers, melanoma, head and neck cancers, basal cell carcinoma and squamous cell carcinoma. It operates through its offices in Tennessee and New York, the US. Provectus is headquartered in Knoxville, Tennessee, the US.
Provectus Biopharmaceuticals Inc (PVCT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Provectus Biopharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Provectus Biopharma Enters into Research Agreement with POETIC 11
Licensing Agreements 12
Provectus to Enter into Licensing Agreement with Sinopharm-CSIPI and Sinopharm A-THINK for PV-10 12
Equity Offering 14
Provectus Biopharma Raises USD6 Million in Public Offering of Series B Preferred Stock and Warrants 14
Provectus Biopharma Raises USD0.8 Million in Private Placement of Shares 16
Provectus Biopharma Raises USD1 Million in Private Placement of Shares 17
Provectus Biopharma Raises USD13.1 Million in Public Offering of Shares and Warrants 18
Provectus Biopharma Raises USD5 Million in Private Placement of Shares 20
Provectus Biopharma Raises USD3.6 Million in Private Placement of Shares 21
Provectus Biopharma Raises USD4.2 Million in Private Placement of Shares 22
Provectus Pharma Announces Private Placement Of Shares For Up To USD 30 Million 23
Provectus Pharma Completes Private Placement Of Units For USD 2 Million 24
Provectus Pharma Completes Private Placement Of Units For USD 2.1 Million 25
Provectus Biopharmaceuticals Inc-Key Competitors 26
Provectus Biopharmaceuticals Inc-Key Employees 27
Provectus Biopharmaceuticals Inc-Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Corporate Communications 29
Apr 20, 2017: Provectus Biopharmaceuticals Reestablishes Strategic Advisory Board 29
Feb 23, 2017: Provectus Biopharmaceuticals Appoints Bruce Horowitz And Dominic Rodrigues As Special Advisers To The Board Of Directors 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31
List Of Figure
List of Figures
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Provectus Biopharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
List Of Table
List of Tables
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Provectus Biopharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Provectus Biopharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Provectus Biopharma Enters into Research Agreement with POETIC 11
Provectus to Enter into Licensing Agreement with Sinopharm-CSIPI and Sinopharm A-THINK for PV-10 12
Provectus Biopharma Raises USD6 Million in Public Offering of Series B Preferred Stock and Warrants 14
Provectus Biopharma Raises USD0.8 Million in Private Placement of Shares 16
Provectus Biopharma Raises USD1 Million in Private Placement of Shares 17
Provectus Biopharma Raises USD13.1 Million in Public Offering of Shares and Warrants 18
Provectus Biopharma Raises USD5 Million in Private Placement of Shares 20
Provectus Biopharma Raises USD3.6 Million in Private Placement of Shares 21
Provectus Biopharma Raises USD4.2 Million in Private Placement of Shares 22
Provectus Pharma Announces Private Placement Of Shares For Up To USD 30 Million 23
Provectus Pharma Completes Private Placement Of Units For USD 2 Million 24
Provectus Pharma Completes Private Placement Of Units For USD 2.1 Million 25
Provectus Biopharmaceuticals Inc, Key Competitors 26
Provectus Biopharmaceuticals Inc, Key Employees 27
Provectus Biopharmaceuticals Inc, Subsidiaries 28
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Products
Provectus Biopharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Related Reports
Page 234 | 
September 2019
Page 140 | July 2019
Page 181 | July 2019
Page 130 | May 2019
Page 155 | April 2019